Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Best of ASCO® Miami 2016 /
Summary of developments in oesophageal and gastric cancers

8th - 10th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.16
Views: 1710

Dr Caio Max Rocha Lima - Gibbs Cancer Center & Research Institute, Spartanburg, South Carolina, USA

Dr Rocha Lima speaks with ecancertv at the Best of ASCO 2016 about developments in treating oesophageal and gastric cancer.

He discusses the negative results of adjuvant radiotherapy to treat cancer around the gastroesophageal junction, and the positive indication for a short course of FOLFOX to treat squamous oesophageal cancer compared to intermittent chemotherapy.

Prof Salah-Eddin Al-Batran introduced results of IMAB362 at this years ASCO conference, and discussed them with ecancer here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation